Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Can this tick biologist and her team of ‘weirdo science’ enthusiasts change the future of scientific research?
4 years ago
Discovery
In Focus
NYU considers hiring former MIT scientist David Sabatini after sexual harassment probe — report
4 years ago
Pharma
In wake of IL-2 shutdown, Nektar lets go of 500+ staffers as it promises a turnaround
4 years ago
R&D
In a surprise move, Novartis CEO Vas Narasimhan recruits top analyst Ronny Gal as new strategy, BD chief
4 years ago
Bear market mauls another small biotech as CEO, board members exit and execs bring out the axe, hunt deals
4 years ago
Black Diamond lays off 30% of its workforce and culls a drug from its 'MasterKey' chest
4 years ago
R&D
Regeneron co-founders slow down compensation in 2021, netting just $13M combined after $270M in 2020
4 years ago
Sandrock’s first month at Voyager sours as shares crumble on Levin, Paul’s move to step off the board
4 years ago
Startups
Bayer plucks another oncology exec away from GlaxoSmithKline as it continues prostate cancer push
4 years ago
R&D
In Frank Clyburn's absence, Merck taps seasoned veteran to run international Human Health business
4 years ago
Pharma
Biotech fraud in ski town saga winds down as ex-president sentenced to 18 months in prison
4 years ago
Bear market shows no signs of abating, claiming Finch Therapeutics as the latest layoff victim
4 years ago
Exclusive: En route to first xenotransplantation trial, eGenesis taps new CEO weeks after CMO hire
4 years ago
Startups
Imara reduced to six employees as the biotech, once again preclinical, explores its options
4 years ago
Magenta feels the biotech blues, announces layoffs and clinical trial cuts
4 years ago
R&D
With Editas' third CEO in as many years, expect a new CMO and new development partners
4 years ago
Cell/Gene Tx
AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days
4 years ago
Startups
Pharma
After February market crash, ProQR will lay off 30% of its workforce and try pushing eye therapy after failed trial
4 years ago
R&D
As antitrust case wraps, Martin Shkreli's lawyers say they're owed $2M+ in unpaid legal fees
4 years ago
Law
Thousands of layoffs planned as part of Novartis restructuring — report
4 years ago
Pharma
Hours after Pfizer, Moderna names its own new CFO with dental, healthcare and auto chops
4 years ago
Pharma
Exclusive: Flagship snags another CEO-partner, on a personal mission, to lead its tRNA boat
4 years ago
Startups
Flagship-backed microbiome company Kaleido Biosciences shuts down
4 years ago
Startups
Harpoon's fall continues as CMO departs weeks after lead program axed
4 years ago
Startups
First page
Previous page
45
46
47
48
49
50
51
Next page
Last page